Basic Information
| RNALocate ID: | RLID:11000865 |
| RNA Symbol: | hsa-miR-26b-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-26b-5p |
| RNA ID: | miRBase:MIMAT0000083 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 22211110 |
| Tissue/Cell Line: | Breast milk |
| Method: | Next-generation RNA sequencing |
|
The expression profile of selected miRNAs in breast milk exosomes. Originally published in Int J Biol Sci. Zhou Q, et al, 2012. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) |
|
| Description: | Distribution and characterization of miRNAs in breast milk exosomes. (A) Distribution of pre-miRNAs. Out of 1,424 pre-miRNAs deposited in miRBase 17.0 (blue circle), 87 (6.11%) pre-miRNAs have been designated as immune-related pre-miRNAs based on annotation in the Pathway Central database (SABiosciences, MD, USA). Immune-related pre-miRNAs (59 of 452, 13.05%) are enriched in breast milk exosomes (red circle). χ2 test: Number of immune-related miRNAs and others detected in breast milk exosomes compared with the total entries in miRBase 17.0. (B) Top ten most highly expressed unique miRNAs. Plot of the unique miRNAs (starting from the miRNA with the highest counts, x-axis) versus their cumulative % of the total counts from 602 unique miRNAs detected in breast milk exosomes for each small RNA library. Values are means ± s.d. The dashed horizontal line at 62.3% represents the level of the top ten unique miRNAs and the % of individual miRNAs is marked by the gray line. (C-E) The expression profile of selected miRNAs in breast milk exosomes. (C) 59 immune-related pre-miRNAs; (D) miR-17-92 cluster and paralogous clusters, and (E) ten well-characterized tissue-specific pre-miRNAs. Data are collected from Figure 2. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001357 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001358 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001359 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001360 | Nucleus | Colon adenocarcinoma cells | 20864815 |
| RLID:11000861 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11000862 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11000863 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11000864 | Exosome | Renal cancer cells | 21670082 |
| RLID:11000866 | Exosome | Brain tissue | 23382797 |
| RLID:11000867 | Exosome | Plasma | 23663360 |
| RLID:11000868 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11000869 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11000870 | Microvesicle | Plasma | 23077538 |
| RLID:11000871 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000019 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000282 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-26b-5p | Diffuse large b cell lymphoma | MNDR-E-MI-33339 |
| MNDR | hsa-miR-26b-5p | Splenic marginal zone lymphoma | MNDR-E-MI-33340 |
| MNDR | hsa-miR-26b-5p | Oral squamous cell carcinoma | MNDR-E-MI-33341 |
| MNDR | hsa-miR-26b-5p | Large cell neuroendocrine cancer | MNDR-E-MI-33342 |
| MNDR | hsa-miR-26b-5p | Medulloblastoma | MNDR-E-MI-33343 |
| MNDR | hsa-miR-26b-5p | B cell lymphoma of malt type | MNDR-E-MI-33344 |
| MNDR | hsa-miR-26b-5p | Ovarian clear cell carcinoma | MNDR-E-MI-33345 |
| MNDR | hsa-miR-26b-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-33346 |
| MNDR | hsa-miR-26b-5p | Lymphoma | MNDR-E-MI-33347 |
| MNDR | hsa-miR-26b-5p | Lymphoma non-hodgkin | MNDR-E-MI-33348 |
| MNDR | hsa-miR-26b-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-33349 |
| MNDR | hsa-miR-26b-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-33350 |
| MNDR | hsa-miR-26b-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-33351 |
| MNDR | hsa-miR-26b-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-33352 |
| MNDR | hsa-miR-26b-5p | Breast cancer luminal | MNDR-E-MI-33353 |
| MNDR | hsa-miR-26b-5p | Niemann-pick disease type c | MNDR-E-MI-33354 |
| MNDR | hsa-miR-26b-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-33355 |
| MNDR | hsa-miR-26b-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-33356 |
| MNDR | hsa-miR-26b-5p | Dermatomyositis | MNDR-E-MI-33357 |
| MNDR | hsa-miR-26b-5p | Prostate cancer | MNDR-E-MI-33358 |
| MNDR | hsa-miR-26b-5p | Gastric cancer | MNDR-E-MI-33359 |
| MNDR | hsa-miR-26b-5p | Gastric lymphoma | MNDR-E-MI-33360 |
| MNDR | hsa-miR-26b-5p | Alzheimer disease | MNDR-E-MI-33361 |
| MNDR | hsa-miR-26b-5p | Intracranial aneurysm | MNDR-E-MI-33362 |
| MNDR | hsa-miR-26b-5p | Urinary bladder cancer | MNDR-E-MI-33363 |
| MNDR | hsa-miR-26b-5p | Esophageal carcinoma | MNDR-E-MI-33364 |
| MNDR | hsa-miR-26b-5p | Dysautonomia familial | MNDR-E-MI-33365 |
| MNDR | hsa-miR-26b-5p | Head and neck cancer | MNDR-E-MI-33366 |
| MNDR | hsa-miR-26b-5p | Lewy body dementia | MNDR-E-MI-33367 |
| MNDR | hsa-miR-26b-5p | Leukemia | MNDR-E-MI-33368 |
| MNDR | hsa-miR-26b-5p | Cardiovascular disease | MNDR-E-MI-33369 |
| MNDR | hsa-miR-26b-5p | Lung cancer | MNDR-E-MI-33370 |
| MNDR | hsa-miR-26b-5p | Parkinson disease | MNDR-E-MI-33371 |
| MNDR | hsa-miR-26b-5p | Niemann-pick disease | MNDR-E-MI-33372 |
| MNDR | hsa-miR-26b-5p | Breast cancer | MNDR-E-MI-33373 |
| MNDR | hsa-miR-26b-5p | Pituitary neoplasms | MNDR-E-MI-33374 |
| MNDR | hsa-miR-26b-5p | Pancreatic cancer | MNDR-E-MI-33375 |
| MNDR | hsa-miR-26b-5p | Melanoma | MNDR-E-MI-33376 |
| MNDR | hsa-miR-26b-5p | Rectum adenocarcinoma | MNDR-E-MI-33377 |
| MNDR | hsa-miR-26b-5p | Nephroblastoma | MNDR-E-MI-33378 |
| MNDR | hsa-miR-26b-5p | Colon cancer | MNDR-E-MI-33379 |
| MNDR | hsa-miR-26b-5p | Colon adenocarcinoma | MNDR-E-MI-33380 |
| MNDR | hsa-miR-26b-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-33381 |
| MNDR | hsa-miR-26b-5p | Ovarian cancer | MNDR-E-MI-33382 |
| MNDR | hsa-miR-26b-5p | Prostate adenocarcinoma | MNDR-E-MI-33383 |
| MNDR | hsa-miR-26b-5p | Laryngeal carcinoma | MNDR-E-MI-33384 |
| MNDR | hsa-miR-26b-5p | Kidney cancer | MNDR-E-MI-33385 |
| MNDR | hsa-miR-26b-5p | Glioblastoma | MNDR-E-MI-33386 |
| MNDR | hsa-miR-26b-5p | Glioma | MNDR-E-MI-33387 |
| MNDR | hsa-miR-26b-5p | Oligodendroglioma | MNDR-E-MI-33388 |
| MNDR | hsa-miR-26b-5p | Central nervous system lymphoma | MNDR-E-MI-33389 |
| MNDR | hsa-miR-26b-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-33390 |
| MNDR | hsa-miR-26b-5p | Epilepsy temporal lobe | MNDR-E-MI-33391 |
| MNDR | hsa-miR-26b-5p | Osteosarcoma | MNDR-E-MI-33392 |
| MNDR | hsa-miR-26b-5p | Inclusion body myositis | MNDR-E-MI-33393 |
| MNDR | hsa-miR-26b-5p | Meningioma | MNDR-E-MI-33394 |
| MNDR | hsa-miR-26b-5p | Liver cancer | MNDR-E-MI-33395 |
| MNDR | hsa-miR-26b-5p | Cervical adenocarcinoma | MNDR-E-MI-33396 |
| MNDR | hsa-miR-26b-5p | Gastric adenocarcinoma | MNDR-E-MI-33397 |
| MNDR | hsa-miR-26b-5p | Cervical squamous cell carcinoma | MNDR-E-MI-33398 |
| MNDR | hsa-miR-26b-5p | Pituitary adenoma | MNDR-E-MI-33399 |
| MNDR | hsa-miR-26b-5p | Lung squamous cell carcinoma | MNDR-E-MI-33400 |
| MNDR | hsa-miR-26b-5p | Non-small cell lung adenocarcinoma | MNDR-E-MI-33401 |
| MNDR | hsa-miR-26b-5p | Lung adenocarcinoma | MNDR-E-MI-33402 |
| MNDR | hsa-miR-26b-5p | Thyroid carcinoma | MNDR-E-MI-33403 |
| MNDR | hsa-miR-26b-5p | Ovarian carcinoma | MNDR-E-MI-33404 |
| MNDR | hsa-miR-26b-5p | Carcinoma renal cell | MNDR-E-MI-33405 |
| MNDR | hsa-miR-26b-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-33406 |
| MNDR | hsa-miR-26b-5p | Renal clear cell carcinoma | MNDR-E-MI-33407 |
| MNDR | hsa-miR-26b-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-33408 |
| MNDR | hsa-miR-26b-5p | Cholangiocarcinoma | MNDR-E-MI-33409 |
| MNDR | hsa-miR-26b-5p | Lung small cell carcinoma | MNDR-E-MI-33410 |
| MNDR | hsa-miR-26b-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-33411 |
| MNDR | hsa-miR-26b-5p | T acute lymphoblastic leukemia | MNDR-E-MI-33412 |
| MNDR | hsa-miR-26b-5p | Acute t cell leukemia | MNDR-E-MI-33413 |
| MNDR | hsa-miR-26b-5p | Acute heart failure | MNDR-E-MI-33414 |
| MNDR | hsa-miR-26b-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-33415 |
| MNDR | hsa-miR-26b-5p | Early hepatocellular carcinoma | MNDR-E-MI-33416 |
| MNDR | hsa-miR-26b-5p | B-cell lymphoma | MNDR-E-MI-33417 |
| MNDR | hsa-miR-26b-5p | Rheumatoid arthritis | MNDR-E-MI-33418 |
| MNDR | hsa-miR-26b-5p | T-cell leukemia | MNDR-E-MI-33419 |
| MNDR | hsa-miR-26b-5p | Neuroblastoma | MNDR-E-MI-33420 |
| MNDR | hsa-miR-26b-5p | Barrett's adenocarcinoma | MNDR-E-MI-33421 |
| MNDR | hsa-miR-26b-5p | Osteoarthritis | MNDR-E-MI-33422 |
| MNDR | hsa-miR-26b-5p | Hodgkin lymphoma | MNDR-E-MI-33423 |
| MNDR | hsa-miR-26b-5p | Ulcerative colitis | MNDR-E-MI-33424 |
| MNDR | hsa-miR-26b-5p | Burkitt lymphoma | MNDR-E-MI-33425 |
| MNDR | hsa-miR-26b-5p | Dementia vascular | MNDR-E-MI-33426 |
| MNDR | hsa-miR-26b-5p | Psoriasis | MNDR-E-MI-33427 |
| MNDR | hsa-miR-26b-5p | Acute myelocytic leukemia | MNDR-E-MI-33428 |
| MNDR | hsa-miR-26b-5p | Colorectal cancer | MNDR-E-MI-33429 |
| MNDR | hsa-miR-26b-5p | Nasopharynx carcinoma | MNDR-E-MI-33430 |
| MNDR | hsa-miR-26b-5p | Multiple myeloma | MNDR-E-MI-33431 |
| MNDR | hsa-miR-26b-5p | Acute lymphocytic leukemia | MNDR-E-MI-33432 |
| MNDR | hsa-miR-26b-5p | Ovarian epithelial cancer | MNDR-E-MI-33433 |
| MNDR | hsa-miR-26b-5p | Cardiomegaly | MNDR-E-MI-33434 |
| MNDR | hsa-miR-26b-5p | Nasopharyngeal cancer | MNDR-E-MI-33435 |
| MNDR | hsa-miR-26b-5p | Stroke lacunar | MNDR-E-MI-33436 |
| MNDR | hsa-miR-26b-5p | Barrett's carcinogenesis | MNDR-E-MI-33437 |
| MNDR | hsa-miR-26b-5p | Breast cancer her3+ negative | MNDR-E-MI-33438 |
| MNDR | hsa-miR-26b-5p | High grade dysplastic nodule | MNDR-E-MI-33439 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCA1 | Homo sapiens | RR00022108 |
TOP